Dr. Melissa R. Keller, MD, PhD

Dr. Keller practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Keller's NPI, 1679923841, was assigned on June 17, 2016. Dr. Keller graduated from Tulane School of Medicine in 2016. Dr. Keller holds California license A191563.

Dr. Keller's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Keller's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. Dr. Keller is also affiliated with Sutter Roseville Medical Center. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Keller to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Keller practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Keller's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Keller's licenses on file in 4 states: California, Texas, North Carolina and Michigan.

Dmand AI lists leg revascularization among the conditions Dr. Keller treats.

CMS data shows 1,672 Medicare services from Dr. Keller across 27 procedure codes in 2024, for 1,062 Medicare patients. Medicare paid $74,546 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,062 Medicare patients who saw Dr. Keller in 2024. The largest group is 65 to 74, with 423 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Keller's median patient age at 67, with 48% women.

In 2024, Dr. Keller wrote 141 Medicare Part D claims for 45 patients. 80% of them were for generic drugs. CMS names the drug for 115 of them, across 4 drugs with 11 or more claims each, at $12,454 in total drug cost. In 2019, CMS named 17 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Keller for performance year 2024, reported as part of a group. Dr. Keller accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Keller as offering telehealth. CMS counts 31 procedures of leg revascularization (restoring blood flow) by Dr. Keller, more than 89% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Keller, published from 2009 to 2024. 2011 was the busiest year, with 2. The most frequent topics are Graft Rejection, Interleukin-17 and Mice, Inbred C57BL. Dr. Keller has published most often in J Vasc Surg Cases Innov Tech. Dr. Keller's most frequent co-authors are Melissa Louise Kirkwood, MD, Carlos Hernando Timaran, MD and Gerardo Gonzalez-Guardiola, MD.

Dmand AI links Dr. Keller to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Aortic Aneurysm, Thoracoabdominal and Aortic Aneurysm, Abdominal.

CMS Open Payments shows 128 general payments to Dr. Keller from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. W. L. Gore & Associates, Inc. paid the most, $4,548.

Dr. Keller graduated from Tulane School of Medicine in 2016.

Dr. Keller is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.